Go here to see the original: Telix Files Form 20-F Registration Statement for Nasdaq ADS
Go here to see the original: Telix Files Form 20-F Registration Statement for Nasdaq ADS
See the original post here: atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
Read more: BioVie Receives Notice of Allowance for Japan Patent Application Covering Novel Liquid Formulation of Terlipressin
Continued here: CervoMed Announces Last Patient Last Visit in Phase 2b RewinD-LB Trial of Neflamapimod for the Treatment of Early-Stage Dementia with Lewy Bodies...
More here: Akari Therapeutics Announces Effectiveness of Form S-4 and General Meeting Date of November 7, 2024 Related to Peak Bio Merger
See the original post here: Palisade Bio Announces Abstract Accepted for Presentation at the American College of Gastroenterology’s (ACG) 2024 Annual Scientific Meeting
Go here to read the rest: Ventyx Biosciences Presents New 52-Week Results from the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024
Here is the original post: NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)
Read the rest here: Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American...
More here: Nipocalimab demonstrates sustained disease control in adolescents living with generalised myasthenia gravis in the Phase 2/3 study
Recent Comments